Navigation Links
VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
Date:10/5/2007

BASKING RIDGE, N.J., Oct. 5 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals (OTC Bulletin Board: VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted cancer therapeutics, announced today that it will present at the BIO InvestorForum on Thursday, October 11, 2007 at 2:00 p.m. Pacific Time at the Palace Hotel in the Sea Cliff Room in San Francisco. Daniel Greenleaf, VioQuest's president and CEO, is scheduled to give an overview of the Company.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070117/NYW085LOGO )

The BioInvestor Forum is dedicated to public and private equity investors, research analysts, investment bankers and senior-level industry executives focused on investment trends and business development opportunities in life sciences

The 4th Annual BIO InvestorForum will showcase to the investment community public and venture-stage growth companies as well as those poised to join the growth "watch list" in the coming year.

About VioQuest Pharmaceuticals

VioQuest focuses on acquiring, developing, and commercializing targeted late preclinical and early clinical stage therapies with unique mechanisms of action primarily for oncology and infectious diseases. VioQuest has three targeted drug candidates in clinical development: VQD-002 which inhibits activation of Akt that is seen at abnormally high levels in breast, ovarian, colorectal, pancreatic, and hematologic cancers; Lenocta(TM), an inhibitor of specific protein tyrosine phosphatases (PTPases), SHP-1 and SHP-2, which has shown compelling clinical and biological activity in solid tumors and Xyfid(TM), a topical therapy which has shown early clinical promise in the treatment and prevention of chemo-induced Hand-Foot Syndrome (HFS). VioQuest anticipates commencing several Phase II trials for VQD-002, Lenocta(TM) and Xyfid(TM) in the s
'/>"/>

SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...New York investment bank KTA Capital,s client Neur...6.7 mil convertible note private placement with a ... was arranged by KTA Capital as Neuren,s exclusive... New York (PRWEB) November 23, 2009 -- The i...LC ("KTA Capital") has announced that it...
(Date:11/24/2009)...IM, Ontario, Nov. 24 Dow...ng the assets of Hyland Seeds, a division of Thomp... Hyland Seeds will further expand Dow AgroSciences...s the introduction of SmartStax(TM) in 2010 ...nology in corn in 2012. The transactional close is...
(Date:11/24/2009)... 24 Sigma-Aldrich Corpor...ASDAQ OMX conference on Tuesday, December 1st at 1...arties may listen via live audio broadcast over th... m a a ldrich.com/ . Users can click the "Web...gma-Aldrich: Sigma-Aldrich is a leading Life Sci...
(Date:11/24/2009)...EYKJAVIK, Iceland, November 24 /PRNewswire-FirstCa... announced the approval of all of its,"first day" ...ict of Delaware,(the "Bankruptcy Court"). deCODE l...er Chapter 11 of the United States Bankruptcy Code...issued by the Bankruptcy Court allow the company t...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...K, Sept. 10 In a major victory for its client,App...g technologies, Weil,Gotshal & Manges LLP won a su...sted life sciences patents. In the action, Enzo Bi...cing reagents and instruments infringed,the patent...Honorable Janet Bond Arterton of the,United States...
...Sept. 10 Sanofi-aventis announced,today a civil s...esolve,"Average Wholesale Price" (AWP) lawsuits un...et(R) involving one of its predecessor companies, ...t relates to government claims that API artificial...increased the cost of,government reimbursements fo...
...POLIS, Sept. 10 BioStorage Technologies, Inc.,(BS...th Indianapolis Power,& Light Company (IPL) to pur...le energy resources, through IPL,s Green Power Opt...ssil-fueled power generation, this,program will be...l by 2009. BST becomes the third-largest customer...
Other Biology Technology:Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 3BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 4
(Date:11/26/2009)... their impressive antlers, red deer have been caug...eer,s antlers are much more than decorative. They ...duelling. John Currey, from The University of York...ies of bone for over half a century and has become... through a long-standing collaboration with Tomas ...
(Date:11/26/2009)...icillin-resistant Staphylococcus Aureus ) and oth... as low-temperature plasma prototype devices have ...iling bactericidal cocktails. , Two prototype de...fection of healthy skin (e.g. hands and feet) in h... a lethal threat; and another to shoot bacteria-ki...
(Date:11/25/2009)...t Larisch, Head of the Cell Death Research Laborat...logy, has been awarded the prestigious Johnson & J...oring the cause of brain cell damage in Parkinson,...o scientists in support of innovation and excellen...ly conferred earlier this month at an event at the...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Eukanuba Unleashes New Free iPhone Application Providing Dog Owners With Instant Access to Dog Parks and Other Four Legged Fun 49737 1Eukanuba Unleashes New Free iPhone Application Providing Dog Owners With Instant Access to Dog Parks and Other Four Legged Fun 49737 2Paulo F Costa Joins MacroGenics Board of Directors 12740 1Paulo F Costa Joins MacroGenics Board of Directors 12740 2Paulo F Costa Joins MacroGenics Board of Directors 12740 3MADIT CRT Trial Meets Primary Endpoint 4632 1MADIT CRT Trial Meets Primary Endpoint 4632 2MADIT CRT Trial Meets Primary Endpoint 4632 3MADIT CRT Trial Meets Primary Endpoint 4632 4
...Tech,s College of Agriculture and Life Sciences ar...scientists that have been awarded $5 million from ...technologies to produce higher quality, disease-re...ensive amount of molecular research has been condu...markers have been used to identify genes controlli...
...number, letter or other shape, neurons in various ...erent components of that shape, almost instantaneo... an image that the individual then "sees" and unde...ty report. , A team from the university,s Zanvyl K...but speedy process in detail in a recent issue of ...
...ic components of living things, are among the most...how proteins form or "fold" from sequenced strings...llenges of biology. , A common belief holds that ...t, the more stable - or less likely to unfold - th...rch issue of Biophysical Journal, a team of chemic...
Other Biology News:Virginia Tech helping to develop higher quality, disease-resistant wheat varieties 2In the mind's eye: How the brain makes a whole out of parts 2UW-Madison engineers squeeze secrets from proteins 2
96 Well Plate Sterile from Thermo Scientific
...he Forma Incubated Console Orbital Shakers combine...g ergonomics, unequalled programming power. The p...m prevents vibration, allowing the unit to run wit...tration system reduces contamination. The heavy s...
HV Mini 3 (230V / 50Hz) from Thermo Scientific
Horizontal Basis 1.2 (230V / 50Hz) from Thermo Scientific
Biology Products: